Lates News

Each Newsflash by AI, Open Securities released a research report on April 21, giving a "buy" rating to Kai Li Medical (300633.SZ). The rating reasons mainly include: 1) Rich product pipeline of research and development innovation, "equipment + AI" results accelerating landing; 2) Steady growth in the domestic market, continuous breakthrough in the overseas market; 3) Significant improvement in performance margins, expected increase in new product volumes, maintaining a "buy" rating. (Daily Economic News)